Pacritinib to Inhibit JAK/STAT Signaling in Refractory Colorectal Cancer
Ontology highlight
ABSTRACT: The investigators propose to assess the efficacy, progression-free survival, and adverse events of pacritinib in patients with refractory colorectal cancer.
DISEASE(S): Colorectal Cancer,Colorectal Neoplasms
PROVIDER: 2177220 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA